Forward Pharma (FWP) Reports Q4 Loss of $1.01/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Forward Pharma Reports Fourth Quarter and Year End 2014 Financial and Operational Results
March 25, 2015 6:30 AM EDTCOPENHAGEN, Denmark, March 25, 2015 (GLOBE NEWSWIRE) -- Forward Pharma A/S (Nasdaq: FWP), today reported financial results for the fourth quarter and year ended December 31, 2014. Net loss for the fourth quarter and year ended December 31, 2014 was $2.0 million and $19.0 million, respectively. Loss per share for the fourth quarter and year ended December 31, 2014 was $1.01 and $1.79, respectively, after accounting for a non-cash preferential distribution of approximately $42.7 million. As of December 31, 2014, Forward had $223.5 million in cash, cash equivalents and marketable securities, with no debt outstanding.
"We expect 2015 to be an eventful year for Forward," said Peder Andersen, Chief Executive... More



